Antioxidants as potential therapeutics in neurodegeneration

Systems Biology of Free Radicals and Antioxidants

Volumn , Issue , 2012, Pages 2191-2273

  Sharma, Sushil ^a   Ebadi, Manuchair ^b  

^a SAINT JAMES SCHOOL OF MEDICINE   (Anguilla)

^b UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Alzheimer's disease; Antioxidants; Charnoly body; Coenzyme Q10< inf>; Drug addiction; Metallothioneins; Neurodegeneration; Neuroprotection; Parkinson's disease; Stem cells; Stroke; Targeting

Indexed keywords

EID: 84929137699     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-30018-9_85     Document Type: Chapter

References (154)

1. Acharya MM, Hattiangady B, Shetty AK (2008) Progress in neuroprotective strategies for preventing epilepsy. Prog Neurobiol 84:363-404
2. Agostinho P, Cunha RA, Oliveira C (2010) Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease. Curr Pharm Des 16:2766-2778
3. Ajjimaporn A, Phansuwan-Pujito P, Govitrapong P (2007) Zinc protects SK-N-SH cells from methamphetamine-induced alpha-synuclein expression. Neurosci Lett 419:59-63
4. Ajjimaporn A, Shavali S, Ebadi M, Govitrapong P (2008) Zinc rescues dopaminergic SK-N-SH cell lines from methamphetamine-induced toxicity. Brain Res Bull 77:361-366
5. Albani D, Polito L, Signorini A, Forloni G (2010) Neuroprotective properties of resveratrol in different neurodegenerative disorders. Biofactors 36:370-376
6. Asanuma M, Miyazaki I, Diaz-Corrales FJ, Kimoto N, Kikkawa Y, Takeshima M, Miyoshi K, Murata M (2010) Neuroprotective effects of zonisamide target astrocyte. Ann Neurol 67:239-249
7. Atik B, Erkutlu I, Tercan M, Buyukhatipoglu H, Bekerecioglu M, Pence S (2011) The effects of exogenous melatonin on peripheral nerve regeneration and collagen formation in rats. J Surg Res 166:330-336
8. Barbeito AG, Martinez-Palma L, Vargas MR, Pehar M, Maay N, Beckman JS, Barbeito L, Cassina P (2010) Lead exposure stimulates VEGF expression in the spinal cord and extends survival in a mouse model of ALS. Neurobiol Dis 37:574-580
9. Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, Shiloh Y, Crawley JN, Ried T, Tagle D, Wynshaw-Boris A (1997) Atm-deficient mice: A paradigm of ataxia telangiectasia. Cell 86:159-171
10. Bilsland LG, Sahai E, Kelly G, Golding M, Greensmith L, Schiavo G (2010) Deficits in axonal transport precede ALS symptoms in vivo. Proc Natl Acad Sci USA 107: 20523-20528
11. Bitel CL, Feng Y, Souayah N, Frederikse PH (2010) Increased expression and local accumulation of the prion protein, Alzheimer Ab2 peptides, superoxide dismutase 1, and nitric oxide synthases 1 & 2 in muscle in a rabbit model of diabetes. BMC Physiol 10:18
12. Bollimuntha S, Singh B, Shavali S, Sharma S, Ebadi M (2005) TRPC1-mediated inhibition of 1-methyl-4-phenylpyridinium Ion neurotoxicity in human SH-SY5Y neuroblastoma cells. J Biol Chem 280:2132-2140
13. Bowman GL, Dodge H, Frei B, Calabrese C, Oken BS, Kaye JA, Quinn JF (2009) Ascorbic acid and rates of cognitive decline in Alzheimer's disease. J Alzheimers Dis 16:93-98
14. Brenneman M, Sharma S, Harting M, Strong R, Cox CS Jr, Aronowski J, Grotta JC, Savitz SI (2010) Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats. J Cereb Blood Flow Metab 30:140-149
15. Brown GC (2010) Nitric oxide and neuronal death. Nitric Oxide 23:153-165
16. Carrasco DI, Bichler EK, Seburn KL, Pinter MJ (2010) Nerve terminal degeneration is independent of muscle fiber genotype in SOD1 mice. PLoS One 5:e9802
17. Carter GT, Abood ME, Aggarwal SK, Weiss MD (2010) Cannabis and amyotrophic lateral sclerosis: hypothetical and practical applications, and a call for clinical trials. Am J Hosp Palliat Care 27:347-356
18. Carvalho C, Santos MS, Baldeiras I, Oliveira CR, Seiça R, Moreira PI (2010) Chronic hypoxia potentiates age-related oxidative imbalance in brain vessels and synaptosomes. Curr Neurovasc Res 7:288-300
19. Carvour M, Song C, Kaul S, Anantharam V, Kanthasamy A, Kanthasamy A (2008) Chronic lowdose oxidative stress induces caspase-3-dependent PKCdelta proteolytic activation and apoptosis in a cell culture model of dopaminergic neurodegeneration. Ann N Y Acad Sci 1139:197-205
20. Castellani RJ, Lee H, Perry G, Smith MA (2006) Antioxidant protection and neurodegenerative disease: The role of amyloid-f3 and tau. Am J Alzheimers Dis Other Demen 21:126-130
21. Chandrasekharan B, Srinivasan S (2007) Diabetes and the enteric nervous system. Neurogastroenterol Motil 19:951-960
22. Chen A, McEwen ML, Sun S, Ravikumar R, Springer JE (2010a) Proteomic and phosphoproteomic analyses of the soluble fraction following acute spinal cord contusion in rats. J Neurotrauma 27:263-274
23. Chen XH, Lin ZZ, Liu AM, Ye JT, Luo Y, Luo YY, Mao XX, Liu PQ, Pi RB (2010b) The orally combined neuroprotective effects of sodium ferulate and borneol against transient global ischemia in C57 BL/6J mice. J Pharm Pharmacol 62:915-923
24. Cho GW, Koh SH, Kim MH, Yoo AR, Noh MY, Oh S, Kim SH (2010) The neuroprotective effect of erythropoietin-transduced human mesenchymal stromal cells in an animal model of ischemic stroke. Brain Res 1353:1-13
25. Choi DK, Koppula S, Suk K (2011) Inhibitors of microglial neurotoxicity: focus on natural products. Molecules 16:1021-1043
26. Cipriani S, Chen X, Schwarzschild MA (2010) Urate: A novel biomarker of Parkinson's disease risk, diagnosis and prognosis. Biomark Med 4:701-712
27. Craggs L, Kalaria RN (2011) Revisiting dietary antioxidants, neurodegeneration and dementia. Neuroreport 22:1-3
28. D'Arrigo A, Colavito D, Penã-Altamira E, Fabris M, Dam M, Contestabile A, Leon A (2010) Transcriptional profiling in the lumbar spinal cord of a mouse model of amyotrophic lateral sclerosis: A role for wild-type superoxide dismutase 1 in sporadic disease. J Mol Neurosci 41:404-415
29. De Araújo DP, Lobato Rde F, Cavalcanti JR, Sampaio LR, Araújo PV, Silva MC, Neves KR, Fonteles MM, Sousa FC, Vasconcelos SM (2011) The contributions of antioxidant activity of lipoic acid in reducing neurogenerative progression of Parkinson's disease: A review. Int J Neurosci 121:51-57
30. Dumont M, Wille E, Stack C, Calingasan NY, Beal MF, Lin MT (2009) Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease. FASEB J 23:2459-2466
31. Ebadi M, Sharma S (2003) Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease. Antioxid Redox Signal 5:319-335
32. Ebadi M, Sharma S (2006) Metallothioneins 1 and 2 attenuate peroxynitrite-induced oxidative stress in Parkinson disease. Exp Biol Med 231:1576-1583
33. Ebadi M, Govitrapong P, Sharma S, Muralikrishnan D, Shavali S, Pellett L, Schafer R, Albano C, Eken J (2001) Ubiquinone (Coenzyme Q10) and mitochondria in oxidative stress of Parkinson's disease. Biol Signals Recept 10:224-253
34. Ebadi M, Sharma S, Wanpen S, Ajjimaporn A (2004) Coenzyme Q10 inhibits mitochondrial complex-1 down-regulation and nuclear factor-kappa B activation. J Cell Mol Med 8:213-222
35. Ebadi M, Brown-Borg H, El Refaey H, Singh BB, Garrett S, Shavali S, Sharma SK (2005a) Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease. Brain Res Mol Brain Res 134:67-75
36. Ebadi M, Sharma S, Ghafourifar P, Bronw-Borg H, Refaey E (2005b) Peroxynitrite in the pathogenesis of Parkinson's disease and the neuroprotective role of metallothioneins. Methods Enzymol 396:276-298
37. Ebadi M, Brown-Borg H, Ren J, Sharma S, Shavali S, El ReFaey H, Carlson E (2006) Therapeutic efficacy of Selegiline in neurodegenerative disorders and neurological diseases. Curr Drug Targets 7:1513-1529
38. Emmez H, Yildirim Z, Kale A, Tange M, Durday E, Barcek AO, Uankuay LN, Doayulu F, Kilian BMK (2010) Anti-apoptotic and neuroprotective effects of a-lipoic acid on spinal cord ischemia-reperfusion injury in rabbits. Acta Neurochir (Wien) 152:1591-1600
39. Ferreiro E, Baldeiras I, Ferreira IL, Costa RO, Rego AC, Pereira CF, Oliveira CR (2012) Mitochondrial-and endoplasmic reticulum-associated oxidative stress in Alzheimer's disease: from pathogenesis to biomarkers. Int J Cell Biol 2012:1-26
40. Fitzgerald M, Bartlett CA, Payne SC, Hart NS, Rodger J, Harvey AR, Dunlop SA (2010) Near infrared light reduces oxidative stress and preserves function in CNS tissue vulnerable to secondary degeneration following partial transection of the optic nerve. J Neurotrauma 27:2107-2119
41. Frank-Cannon TC, Tran T, Ruhn KA, Martinez TN, Hong J, Marvin M, Hartley M, Trevio I, O'Brien DE, Casey B, Goldberg MS, Tansey MG (2008) Parkin deficiency increases vulnerability to inflammation-related nigral degeneration. J Neurosci 28:10825-10834
42. Garg P, Duncan RS, Kaja S, Koulen P (2010) Intracellular mechanisms of N-acylethanolaminemediated neuroprotection in a rat model of stroke. Neuroscience 166:252-262
43. Gilgun-Sherki Y, Melamed E, Offen D (2001) Oxidative stress induced-neurodegenerative diseases: The need for antioxidants that penetrate the blood brain barrier. Neuropharmacology 40:959-975
44. Goryacheva AV, Kruglov SV, Pshennikova MG, Smirin BV, Malyshev IY, Barskov IV, Viktorov IV, Downey HF, Manukhina EB (2010) Adaptation to intermittent hypoxia restricts nitric oxide overproduction and prevents beta-amyloid toxicity in rat brain. Nitric Oxide 23:289-299
45. Gupta YK, Chauhan A (2011) Potential of immunosuppressive agents in cerebral ischaemia. Indian J Med Res 133:15-26
46. Gutierrez-Merino C, Lopez-Sanchez C, Lagoa R, Samhan-Arias AK, Bueno C, Garcia-Martinez V (2011) Neuroprotective actions of flavonoids. Curr Med Chem 18:1195-1212
47. Hall AA, Leonardo CC, Collier LA, Rowe DD, Willing AE, Pennypacker KR (2009) Delayed treatments for stroke influence neuronal death in rat organotypic slice cultures subjected to oxygen glucose deprivation. Neuroscience 164:470-477
48. Hamed SA (2010) The multimodal prospects for neuroprotection and disease modification in epilepsy: relationship to its challenging neurobiology. Restor Neurol Neurosci 28:323-348
49. Hanish Singh JC, Alagarsamy V, Sathesh Kumar S, Narsimha Reddy Y (2011) Neurotransmitter metabolic enzymes and antioxidant status on Alzheimer's disease induced mice treated with Alpinia galanga (L.) Willd. Phytother Res 25(7):1061-1067
50. Haorah J, Ramirez SH, Floreani N, Gorantla S, Morsey B, Persidsky Y (2008) Mechanism of alcohol-induced oxidative stress and neuronal injury. Free Radic Biol Med 45:1542-1550
51. Heiman-Patterson TD, Sher RB, Blankenhorn EA, Alexander G, Deitch JS, Kunst CB, Maragakis N, Cox G (2011) Effect of genetic background on phenotype variability in transgenic mouse models of amyotrophic lateral sclerosis: A window of opportunity in the search for genetic modifiers. Amyotroph Lateral Scler 12:79-86
52. Hozumi I, Asanuma M, Yamada M, Uchida Y (2004) Metallothioneins and neurodegenerative diseases. J Health Sci 50:323-331
53. Ishrat T, Parveen K, Hoda MN, Khan MB, Yousuf S, Ansari MA, Saleem S, Islam F (2009) Effects of pycnogenol and vitamin E on cognitive deficits and oxidative damage induced by intracerebroventricular Streptozotocin in rats. Behav Pharmacol 20:567-575
54. Itoh M, Ebadi M, Swanson S (1983) The presence of zinc binding proteins in brain. J Neurochem 41:823-829
55. Junk AK, Mammis A, Savitz SI, Singh M, Roth S, Malhotra S, Rosenbaum PS, Cerami A, Brines M, Rosenbaum DM (2002) Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci USA 99:10659-10664
56. Kalonia H, Kumar P, Kumar A, Nehru B (2010) Protective effect of montelukast against quinolinic acid/malonic acid induced neurotoxicity: possible behavioral, biochemical, mitochondrial and tumor necrosis factor-A level alterations in rats. Neuroscience 171:284-299
57. Kanu N, Penicud K, Hristova M, Wong B, Irvine E, Plattner F, Raivich G, Behrens A (2010) The ATM cofactor ATMIN protects against oxidative stress and accumulation of DNA damage in the aging brain. J Biol Chem 285:38534-38542
58. Katsuki H (2010) Exploring neuroprotective drug therapies for intracerebral hemorrhage. J Pharmacol Sci 114:366-378
59. Kelsey NA, Wilkins HM, Linseman DA (2010) Nutraceutical antioxidants as novel neuroprotective agents. Molecules 15:7792-7814
60. Kemp K, Gray E, Mallam E, Scolding N, Wilkins A (2010) Inflammatory cytokine induced regulation of superoxide dismutase 3 expression by human mesenchymal stem cells. Stem Cell Rev 6:548-559
61. Kieran D, Woods I, Villunger A, Strasser A, Prehn JH (2007) Deletion of the BH3-only protein puma protects motoneurons from ER stress-induced apoptosis and delays motoneuron loss in ALS mice. Proc Natl Acad Sci USA 104:20606-20611
62. Kim D, Nguyen MD, Dobbin MM, Fischer A, Sananbenesi F, Rodgers JT, Delalle I, Baur JA, Sui G, Armour SM, Puigserver P, Sinclair DA, Tsai LH (2007) SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J 26:3169-3179
63. Kim J, Moody JP, Edgerly CK, Bordiuk OL, Cormier K, Smith K, Beal MF, Ferrante RJ (2010) Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease. Hum Mol Genet 19:3919-3935
64. Kind B, Koehler K, Krumbholz M, Landgraf D, Huebner A (2010) Intracellular ROS level is increased in fibroblasts of triple A syndrome patients. J Mol Med 88:1233-1242
65. Kirby J, Ning K, Ferraiuolo L, Heath PR, Ismail A, Kuo SW, Valori CF, Cox L, Sharrack B, Wharton SB, Ince PG, Shaw PJ, Azzouz M (2011) Phosphatase and tensin homologue/protein kinase B pathway linked to motor neuron survival in human superoxide dismutase 1-related amyotrophic lateral sclerosis. Brain 134:506-517
66. Klongpanichapak S, Govitrapong P, Sharma S, Ebadi M (2006) Attenuation of cocaine and methamphetamine neurotoxicity by coenzyme Q10. Neurochem Res 31:303-311
67. Kobayashi Z, Tsuchiya K, Kubodera T, Shibata N, Arai T, Miura H, Ishikawa C, Kondo H, Ishizu H, Akiyama H, Mizusawa H (2011) FALS with Gly72Ser mutation in SOD1 gene: report of a family including the first autopsy case. J Neurol Sci 300:9-13
68. Kooncumchoo P, Sharma S, Porter J, Govitrapong P, Ebadi M (2006) Coenzyme Q10 provides neuroprotection in iron-induced apoptosis in dopaminergic neurons. J Mol Neurosci 28:125-141
69. Kweon GR, Marks JD, Krencik R, Leung EH, Schumacker PT, Hyland K, Kang UJ (2004) Distinct mechanisms of neurodegeneration induced by chronic complex I inhibition in dopaminergic and non-dopaminergic cells. J Biol Chem 279:51783-51792
70. Lahaie-Collins V, Bournival J, Plouffe M, Carange J, Martinoli MG (2008) Sesamin modulates tyrosine hydroxylase, superoxide dismutase, catalase, inducible NO synthase and interleukin-6 expression in dopaminergic cells under MPP+-induced oxidative stress. Oxid Med Cell Longev 1:54-62
71. Lee CH, Yoo KY, Choi JH, Park OK, Hwang IK, Kwon YG, Kim YM, Won MH (2010a) Melatonin's protective action against ischemic neuronal damage is associated with upregulation of the MT2 melatonin receptor. J Neurosci Res 88:2630-2640
72. Lee CH, Yoo KY, Hwang IK, Choi JH, Park OK, Li H, Kang IJ, Kwon YG, Kim YM, Won MH (2010b) Hypothyroid state does not protect but delays region following transient cerebral ischemia: focus on oxidative stress and gliosis. J Neurosci Res 88:2661-2668
73. Lehtinen MK, Tegelberg S, Schipper H, Su H, Zukor H, Manninen O, Kopra O, Joensuu T, Hakala P, Bonni A, Lehesjoki AE (2009) Cystatin B deficiency sensitizes neurons to oxidative stress in progressive myoclonus epilepsy, EPM1. J Neurosci 29:5910-5915
74. Lenzken SC, Romeo V, Zolezzi F, Cordero F, Lamorte G, Bonanno D, Biancolini D, Cozzolino M, Pesaresi MG, Maracchioni A, Sanges R, Achsel T, Carrì MT, Calogero RA, Barabino SM (2011) Mutant SOD1 and mitochondrial damage alter expression and splicing of genes controlling neuritogenesis in models of neurodegeneration. Hum Mutat 32:168-182
75. Leonardo CC, Hall AA, Collier LA, Ajmo CT Jr, Willing AE, Pennypacker KR (2010) Human umbilical cord blood cell therapy blocks the morphological change and recruitment of CD11bexpressing, isolectin-binding proinflammatory cells after middle cerebral artery occlusion. J Neurosci Res 88:1213-1222
76. Li W, Wu S, Ahmad M, Jiang J, Liu H, Nagayama T, Rose ME, Tyurin VA, Tyurina YY, Borisenko GG, Belikova N, Chen J, Kagan VE, Graham SH (2010) The cyclooxygenase site, but not the peroxidase site of cyclooxygenase-2 is required for neurotoxicity in hypoxic and ischemic injury. J Neurochem 113:965-977
77. Liang X, Wang Q, Shi J, Lokteva L, Breyer RM, Montine TJ, Andreasson K (2008) The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis. Ann Neurol 64:304-314
78. Lim J, Ali ZM, Sanders RA, Snyder AC, Eells JT, Henshel DS, Watkins JB 3rd (2009) Effects of low-level light therapy on hepatic antioxidant defense in acute and chronic diabetic rats. J Biochem Mol Toxicol 23:1-8
79. Lin HW, Lee EJ (2009) Effects of melatonin in experimental stroke models in acute, sub-acute, and chronic stages. Neuropsychiatr Dis Treat 5:157-162
80. Liu PK, Robertson CS, Valadka A (2002) The association between neuronal nitric oxide synthase and neuronal sensitivity in the brain after brain injury. Ann N Y Acad Sci 962:226-241
81. Liu J, Lillo C, Jonsson PA, Vande Velde C, Ward CM, Miller TM, Subramaniam JR, Rothstein JD, Marklund S, Andersen PM, Brannstrom T, Gredal O, Wong PC, Williams DS, Cleveland DW (2004) Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron 43:5-17
82. Liu Y, Chen HL, Yang G (2010) Extract of Tripterygium wilfordii hook F protect dopaminergic neurons against lipopolysaccharide-induced inflammatory damage. Am J Chin Med 38:801-814
83. Lunn JS, Sakowski SA, Kim B, Rosenberg AA, Feldman EL (2009) Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration. Dev Neurobiol 69:871-884
84. Malhotra S, Savitz SI, Ocava L, Rosenbaum DM (2006) Ischemic preconditioning is mediated by erythropoietin through PI-3 kinase signaling in an animal model of transient ischemic attack. J Neurosci Res 83:19-27
85. Manukhina EB, Goryacheva AV, Barskov IV, Viktorov IV, Guseva AA, Pshennikova MG, Khomenko IP, Mashina SY, Pokidyshev DA, Malyshev IY (2010) Prevention of neurodegenerative damage to the brain in rats in experimental Alzheimer's disease by adaptation to hypoxia. Neurosci Behav Physiol 40:737-743
86. Marghoshes M, Vellee BL (1957) A cadmium protein from equine kidney cortex. J Am Chem Soc 79:4813-4814
87. Marks JD, Boriboun C, Wang J (2005) Mitochondrial nitric oxide mediates decreased vulnerability of hippocampal neurons from immature animals to NMDA. J Neurosci 25:6561-6575
88. Martinez de Morentin PB, Gonzalez CR, LopezM (2010) AMP-activated protein kinase: 'a cup of tea' against cholesterol-induced neurotoxicity. J Pathol 222:329-334
89. Martins RDP, Braga HDC, da Sliva AP, Dalmarco JB, de Bem AF, dos Santos ARS, Dafre AL, Pizzaolatti MG, Latini A, Aschner M, Farina M (2009) Synergistic neurotoxicity induced by methylmercury and quercetin in mice. Food Chem Toxicol 47:645-649
90. Meehan CF, Moldovan M, Marklund SL, Graffmo KS, Nielsen JB, Hultborn H (2010) Intrinsic properties of lumbar motor neurones in the adult G127insTGGG superoxide dismutase-1 mutant mouse in vivo: evidence for increased persistent inward currents. Acta Physiol (Oxf) 200:361-376
91. Merino JJ, Montes ML, Blanco A, Bustos MJ, Oreja-Guevara C, Bayón C, Cuadrado A, Lubrini G, Cambrón I, Munõz A, Cebolla S, Gutiérrez-Fernández M, Bernardino JI, Arribas JR, Fiala M (2011a) HIV-1 neuropathogenesis: therapeutic strategies against neuronal loss induced by gp120/Tat glycoprotein in the central nervous system. Rev Neurol 52:101-111
92. Merino JJ, Montes ML, Blanco A, Bustos MJ, Oreja-Guevara C, Bayon C, Cuadrado A, Lubrini G, Cambron I, Munoz A, Cebolla S, Gutierrez-Fernandez M, Bernardino JI, Arribas JR, Fiala M, Milanese M, Zappettini S, Onofri F, Musazzi L, Tardito D, Bonifacino T, Messa M, Racagni G, Usai C, Benfenati F, Popoli M, Bonanno G (2011b) Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis. J Neurochem 116:1028-1042
93. Mocko JB, Kern A, Moosmann B, Behl C, Hajieva P (2010) Phenothiazines interfere with dopaminergic neurodegeneration in Caenorhabditis elegans models of Parkinson's disease. Neurobiol Dis 40:120-129
94. Moreira PI, Zhu X, Wang X, Lee HG, Nunomura A, Petersen RB, Perry G, Smith MA (2010) Mitochondria: A therapeutic target in neurodegeneration. Biochim Biophys Acta 1802:212-220
95. Moszczynska A, Yamamoto BK (2011) Methamphetamine oxidatively damages parkin and decreases the activity of 26S proteasome in vivo. J Neurochem 116:1005-1017
96. Nam KN, Park YM, Jung HJ, Lee JY, Min BD, Park SU, Jung WS, Cho KH, Park JH, Kang I, Hong JW, Lee EH (2010) Anti-inflammatory effects of crocin and crocetin in rat brain microglial cells. Eur J Pharmacol 648:110-116
97. Nicaise C, Mitrecic D, Pochet R (2011) Brain and spinal cord affected by amyotrophic lateral sclerosis induce differential growth factors expression in rat mesenchymal and neural stem cells. Neuropathol Appl Neurobiol 37:179-188
98. Nopparat C, Porter J, Ebadi M, Govitrapong P (2010) The mechanism for the neuroprotective effect of melatonin against methamphetamine-induced autophagy. J Pineal Res 49:382-389
99. Ock J, Han HS, Hong SH, Lee SY, Han YM, Kwon BM, Suk K (2010) Obovatol attenuates microglia-mediated neuroinflammation by modulating redox regulation. Br J Pharmacol 159:1646-1662
100. Oliveira LT, Louzada PR, de Mello FG, Ferreira ST (2011) Amyloid-b decreases nitric oxide production in cultured retinal neurons: A possible mechanism for synaptic dysfunction in Alzheimer's disease? Neurochem Res 36:163-169
101. Papadimitriou D, Le Verche V, Jacquier A, Ikiz B, Przedborski S, Re DB (2010) Inflammation in ALS and SMA: sorting out the good from the evil. Neurobiol Dis, 37, 493-502
102. Peng J, Stevenson FF, Oo ML, Andersen JK (2009) Iron-enhanced paraquat-mediated dopaminergic cell death due to increased oxidative stress as a consequence of microglial activation. Free Radic Biol Med 46:312-320
103. Perlson E, Jeong GB, Ross JL, Dixit R, Wallace KE, Kalb RG, Holzbaur EL (2009) A switch in retrograde signaling from survival to stress in rapid-onset neurodegeneration. J Neurosci 29:9903-9917
104. Ramkissoon A, Wells PG (2011) Human prostaglandin H synthase (hPHS)-1-and hPHS-2-dependent bioactivation, oxidative macromolecular damage, and cytotoxicity of dopamine, its precursor, and its metabolites. Free Radic Biol Med 50:295-304
105. Rao AV, Balachandran B (2002) Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutr Neurosci 5:291-309
106. Sangchot P, Sharma S, Chetsawang B, Porter J, Govitrapong P, Ebadi M (2002) Deferoxamine attenuates iron-induced oxidative stress and prevents mitochondrial aggregation and alphasynuclein translocation in SK-N-SH cells in culture. Dev Neurosci 24:143-153
107. Sen CK, Rink C, Khanna S (2010) Palm oil-derived natural vitamin E alpha-tocotrienol in brain health and disease. J Am Coll Nutr 29:314S-323S
108. Sharma S, Ebadi M(2003) Metallothionein attenuates 3-morpholinosydnonimine (SIN-1)-induced oxidative stress in dopaminergic neurons. Antioxid Redox Signal 5:251-264
109. Sharma S, Ebadi M (2004) An improved method for analyzing coenzyme Q homologues and multiple detection of rare biological samples. J Neurosci Methods 137:1-8
110. Sharma SK, EbadiM(2005) Distribution kinetics of 18F-DOPA in weaver mutant mice. Brain Res Mol Brain Res 139:23-30
111. Sharma S, Ebadi M (2008a) Therapeutic potential of metallothioneins in Parkinson's disease. In: Hahn TF, Werner J (eds) New research in Parkinson's disease. Nova Science Publishers, New York, pp 1-41
112. Sharma S, Ebadi M (2008b) SPECT neuroimaging in translational research of CNS disorders. Neurochem Int 52:352-362
113. Sharma S, Yang B, Strong R, Xi X, Brenneman M, Grotta JC, Aronowski J, Savitz SI (2010) Bone marrow mononuclear cells protect neurons and modulate microglia in cell culture models of ischemic stroke. J Neurosci Res 88:2869-2876
114. Sharma SK, Yang B, Xi X, Grotta JC, Aronowski J, Svitz SI (2011) IL-10 directly protects cortical neurons by activating PI-3 kinase and STAT-3 pathways. Brain Res 1373:189-194
115. Sharma S, EbadiM(2011a) Metallothioneins as early & sensitive biomarkers of redox signaling in neurodegenerative disorders. IIOAB J 2:98-106
116. Sharma S, Ebadi M(2011b) Therapeutic potential of metallothioneins as anti-inflammatory agents in polysubstance abuse. IIOAB J 2:50-61
117. Sharma S, Ebadi M (2012) In-vivo molecular imaging in Parkinson's disease. In: Ebadi M, Pfiffer R (eds) Parkinson's disease. CRC Press, Boca Raton
118. Sharma S, Carlson E, EbadiM(2003) Neuroprotective actions of Selegiline in inhibiting 1-methyl, 4-phenyl, pyridinium ion (MPP+)-induced apoptosis in SK-N-SH neurons. J Neurocytol 32:329-343
119. Sharma S, Kheradpezhou M, Shavali S, El Refaey H, Eken J, Hagen C, Ebadi M (2004) Neuroprotective actions of coenzyme Q10 in Parkinson's disease. Methods Enzymol 382:488-509
120. Sharma S, El ReFaey H, Ebadi M (2006) Complex-1 activity and 18F-DOPA uptake in genetically engineered mouse model of Parkinson's disease and the neuroprotective role of coenzyme Q10. Brain Res Bull 70:22-32
121. Sharma S, Yang B, Strong R, Xi X, Brenneman M, Grotta J, Aronowski J, Savitz S (2010) Bone marrow mononuclear cells protect neurons and modulate microglia in cell culture models of ischemic stroke. J Neurosci Res 88:2869-2876
122. Sharma S, Rais A, Sandhu R, Nel W, Ebadi M (2013) Clinical significance of metallothioneins in cell therapy and nanomedicine. Int J Nanomedicine 8:1477-1488
123. Siddiqui A, Mallajosyula JK, Rane A, Andersen JK (2010) Ability to delay neuropathological events associated with astrocytic MAO-B increase in a Parkinsonian mouse model: implications for early intervention on disease progression. Neurobiol Dis 40:444-448
124. Singh RP, Sharad S, Kapur S (2004) Free radicals and oxidative stress in neurodegenerative diseases: relevance of dietary antioxidant. JIACM 5:218-225
125. Song C, Kanthasamy A, Anantharam V, Sun F, Kanthasamy AG (2010) Environmental neurotoxic pesticide increases histone acetylation to promote apoptosis in dopaminergic neuronal cells: relevance to epigenetic mechanisms of neurodegeneration. Mol Pharmacol 77:621-632
126. Spillantini MG, Goedert M (2000) The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Ann N Y Acad Sci 920:16-27
127. Spring K, Cross S, Li C, Watters D, Ben-Senior L, Waring P, Ahangari F, Lu S, Chen P, Misko I, Paterson C, Kay G, Smorodinsky NI, Shiloh Y, Lavin MF (2001) Atm knock-in mice harboring an in-frame deletion corresponding to the human ATM 7636del9 common mutation exhibit a variant phenotype. Cancer Res 61:4561-4568
128. Srikanth V, Maczurek A, Phan T, Steele M, Westcott B, Juskiw D, Münch G (2011) Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease. Neurobiol Aging 32:763-777
129. Stadler K (2011) Peroxynitrite-driven mechanisms in diabetes and insulin resistance -the latest advances. Curr Med Chem 18:280-290
130. Sunico CR, Domínguez G, García-Verdugo JM, Osta R, Montero F, Moreno-López B (2011) Reduction in the motoneuron inhibitory/excitatory synaptic ratio in an early-symptomatic mouse model of amyotrophic lateral sclerosis. Brain Pathol 21:1-15
131. Surendran S, Rajasankar S (2010) Parkinson's disease: oxidative stress and therapeutic approaches. Neurol Sci 31:531-540
132. Suzuki S, Masui Y, Ohnuki M, Miyakoda G, Mori T, Nakajima K, Sato M (2007) Induction of metallothionein synthesis by cilostazol in mice and in human cultured neuronal cell lines. Biol Pharm Bull 30:791-794
133. Underwood BR, Imarisio S, Fleming A, Rose R, Krishna G, Heard P, Quick M, Korolchuk VI, Renna M, Sarkar S, Arencibia MG, O'Kane CJ, Murphy MP, Rubinsztein DC (2010) Antioxidants can inhibit basal autophagy and enhance neurodegeneration in models of polyglutamine disease. Hum Mol Genet 17:3413-3429
134. van Eersel J, Ke YD, Liu X, Delerue F, Kril JJ, Götz J, Ittner LM (2010) Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models. Proc Natl Acad Sci USA 107:13888-13893
135. van Zundert B, Peuscher MH, Hynynen M, Chen A, Neve RL, Brown RH Jr, Constantine-Paton M, Bellingham MC (2008) Neonatal neuronal circuitry shows hyperexcitable disturbance in a mouse model of the adult-onset neurodegenerative disease amyotrophic lateral sclerosis. J Neurosci 28:10864-10874
136. Vargas MR, Johnson DA, Sirkis DW, Messing A, Johnson JA (2008) Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. J Neurosci 28:13574-13581
137. Vassall KA, Stubbs HR, Primmer HA, Tong MS, Sullivan SM, Sobering R, Srinivasan S, Briere LA, Dunn SD, Colón W, Meiering EM (2011) Decreased stability and increased formation of soluble aggregates by immature superoxide dismutase do not account for disease severity in ALS. Proc Natl Acad Sci USA 108:2210-2215
138. Wakida K, Morimoto N, ShimazawaM, Hozumi I, Nagase H, Inuzuka T, Hara H (2006) Cilostazol reduces ischemic brain damage partly by inducing metallothionein-1 and -2. Brain Res 1116:187-193
139. Wakida K, Shimazawa M, Hozumi I, Satoh M, Nagase H, Inuzuka T, Hara H (2007) Neuroprotective effect of erythropoietin, and role of metallothionein-1 and -2, in permanent focal cerebral ischemia. Neuroscience 148:105-114
140. Wang Y, Mao XO, Xie L, Banwait S, Marti HH, Greenberg DA, Jin K (2007) Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice. J Neurosci 27:304-307
141. Wilcox CS (2010) Effects of tempol and redox-cycling nitroxides in models of oxidative stress. Pharmacol Ther 126:119-145
142. Wirth EK, Conrad M, Winterer J, Wozny C, Carlson BA, Roth S, Schmitz D, Bornkamm GW, Coppola V, Tessarollo L, Schomburg L, Köhrle J, Hatfield DL, Schweizer U (2010) Neuronal selenoprotein expression is required for interneuron development and prevents seizures and neurodegeneration. FASEB J 24:844-852
143. Witherick J, Wilkins A, Scolding N, Kemp K (2011) Mechanisms of oxidative damage in multiple sclerosis and a cell therapy approach to treatment. Autoimmune Dis 2011:1-11
144. Xu K, Puchowicz MA, Sun X, LaManna JC (2010) Decreased brain stem function following cardiac arrest and resuscitation in aged rat. Brain Res 1328:181-189
145. Yang H, Baur JA, Chen A, Miller C, Adams JK, Kisielewski A, Howitz KT, Zipkin RE, Sinclair DA (2007) Design and synthesis of compounds that extend yeast replicative lifespan. Aging Cell 6:35-43
146. Yang G, Meng Y, Li W, Yong Y, Fan Z, Ding H, Wei Y, Luo J, Ke ZJ (2011) Neuronal MCP-1 mediates microglia recruitment and neurodegeneration induced by the mild impairment of oxidative metabolism. Brain Pathol 21:279-297
147. Yokoyama H, Yano R, Kuroiwa H, Tsukada T, Uchida H, Kato H, Kasahara J, Araki T (2010) Therapeutic effect of a novel anti-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice. Metab Brain Dis 25:135-143
148. Yoon IS, Au Q, Barber JR, Ng SC, Zhang B (2010) Development of a high-throughput screening assay for cytoprotective agents in rotenone-induced cell death. Anal Biochem 407:205-210
149. Yousuf S, Atif F, Ahmad M, Hoda N, Ishrat T, Khan B, Islam F (2009) Resveratrol exerts its neuroprotective effect by modulating mitochondrial dysfunctions and associated cell death during cerebral ischemia. Brain Res 1250:242-253
150. Zhang T, Mi Z, Schor NF (2009) Role of tyrosine phosphorylation in the antioxidant effects of the p75 neurotrophin receptor. Oxid Med Cell Longev 2:238-246
151. Zhang M, Xu JT, Zhu X, Wang Z, Zhao X, Hua Z, Tao YX, Xu Y (2010) Postsynaptic density-93 deficiency protects cultured cortical neurons from N-methyl-D-aspartate receptor-triggered neurotoxicity. Neuroscience 166:1083-1090
152. Zhang L, Haraguchi S, Koda T, Hashimoto K, Nakagawara A (2011) Muscle atrophy and motor neuron degeneration in human NEDL1 transgenic mice. J Biomed Biotechnol 2011:1-7
153. Zhao B (2005) Natural antioxidants for neurodegenerative diseases. Mol Neurobiol 31:283-293
154. Zhao Y, Zhao B (2012) Natural antioxidants in prevention and management of Alzheimer's disease. Front Biosci 4:794-808